Promotion of tumor progression induced by continuous low-dose administration of antineoplastic agent gemcitabine or gemcitabine combined with cisplatin
- Resource Type
- Article
- Source
- In
Life Sciences 1 October 2022 306 - Subject
- Language
- ISSN
- 0024-3205